0001225208-20-012815.txt : 20201029 0001225208-20-012815.hdr.sgml : 20201029 20201029205050 ACCESSION NUMBER: 0001225208-20-012815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201029 FILED AS OF DATE: 20201029 DATE AS OF CHANGE: 20201029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szyman Catherine M. CENTRAL INDEX KEY: 0001438538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 201274406 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER NAME: FORMER CONFORMED NAME: Szyman Catherine M DATE OF NAME CHANGE: 20080625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2020-10-29 0001099800 Edwards Lifesciences Corp EW 0001438538 Szyman Catherine M. ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Critical Care Common Stock 2020-10-29 4 M 0 20355.0000 22.2867 A 47101.1397 D Common Stock 2020-10-29 4 S 0 20355.0000 73.2441 D 26746.1397 D Employee Stock Option (Right to Acquire) 22.2867 2020-10-29 4 M 0 20355.0000 0.0000 D 2016-02-19 2022-02-18 Common Stock 20355.0000 20355.0000 D This transaction was executed in multiple trades at prices ranging from $72.9800 to $73.4300. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2020-10-29